Yinchun Ji

934 total citations
51 papers, 802 citations indexed

About

Yinchun Ji is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Yinchun Ji has authored 51 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Hepatology. Recurrent topics in Yinchun Ji's work include Liver physiology and pathology (19 papers), Cancer Mechanisms and Therapy (10 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Yinchun Ji is often cited by papers focused on Liver physiology and pathology (19 papers), Cancer Mechanisms and Therapy (10 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Yinchun Ji collaborates with scholars based in China, United States and Germany. Yinchun Ji's co-authors include Meiyu Geng, Jing Ai, Peng Xia, Peng Xia, Yang Claire Yang, Ting Li, Zilan Song, Wenhu Duan, Ao Zhang and Zushang Su and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yinchun Ji

47 papers receiving 792 citations

Peers

Yinchun Ji
Wufu Zhu China
Sung Yun Cho South Korea
Peter D. Gorycki United States
Yunting Luo United States
Joachim Blanz Germany
Gregory R. Ott United States
Emile G. Plise United States
Yali Deng China
Asaad Nematalla United States
Wufu Zhu China
Yinchun Ji
Citations per year, relative to Yinchun Ji Yinchun Ji (= 1×) peers Wufu Zhu

Countries citing papers authored by Yinchun Ji

Since Specialization
Citations

This map shows the geographic impact of Yinchun Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinchun Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinchun Ji more than expected).

Fields of papers citing papers by Yinchun Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinchun Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinchun Ji. The network helps show where Yinchun Ji may publish in the future.

Co-authorship network of co-authors of Yinchun Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Yinchun Ji. A scholar is included among the top collaborators of Yinchun Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinchun Ji. Yinchun Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Qianqian, Fang Chen, Yinchun Ji, et al.. (2024). Synthesis and evaluation of hybrid molecules as RIPK1 and HDACs dual inhibitors. Journal of Molecular Structure. 1318. 139238–139238. 2 indexed citations
2.
3.
Xia, Peng, Yinchun Ji, Yi Su, et al.. (2023). Discovery of a 1,6-naphthyridin-4-one-based AXL inhibitor with improved pharmacokinetics and enhanced in vivo antitumor efficacy. European Journal of Medicinal Chemistry. 265. 116045–116045. 1 indexed citations
4.
Xia, Peng, Yinchun Ji, Yang Dai, et al.. (2021). The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation. Molecular Cancer Therapeutics. 20(11). 2198–2206. 9 indexed citations
5.
Xu, Dandan, Wei Wang, Peng Xia, et al.. (2021). Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 220. 113497–113497. 18 indexed citations
6.
7.
Ji, Yinchun, Peng Xia, Yinglei Gao, et al.. (2020). SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors. Acta Pharmacologica Sinica. 42(6). 998–1004. 13 indexed citations
8.
Wang, Yueliang, Xing Li, Yinchun Ji, et al.. (2019). Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amino)pyrazine core. Bioorganic & Medicinal Chemistry Letters. 29(6). 836–838. 7 indexed citations
9.
Wang, Qi, Yang Dai, Yinchun Ji, et al.. (2018). Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma. European Journal of Medicinal Chemistry. 163. 671–689. 14 indexed citations
10.
Ai, Jing, Yi Chen, Peng Xia, et al.. (2017). Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. Molecular Cancer Therapeutics. 17(4). 751–762. 26 indexed citations
11.
Song, Zilan, Yinchun Ji, Xing Li, et al.. (2016). An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core. European Journal of Medicinal Chemistry. 118. 244–249. 12 indexed citations
12.
Ai, Jing, Shiyu Jin, Peng Xia, et al.. (2015). Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis. European Journal of Medicinal Chemistry. 95. 302–312. 35 indexed citations
13.
Jiang, Xiaolong, Hongyan Liu, Zilan Song, et al.. (2014). Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold. Bioorganic & Medicinal Chemistry. 23(3). 564–578. 15 indexed citations
14.
Liu, Zhiqing, Jing Ai, Peng Xia, et al.. (2014). Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities. ACS Medicinal Chemistry Letters. 5(4). 304–308. 27 indexed citations
15.
Zhang, Wei, Jing Ai, Peng Xia, et al.. (2014). Discovery of novel type II c-Met inhibitors based on BMS-777607. European Journal of Medicinal Chemistry. 80. 254–266. 25 indexed citations
16.
Yang, Yang Claire, Ting Li, & Yinchun Ji. (2013). Impact of social integration on metabolic functions: evidence from a nationally representative longitudinal study of US older adults. BMC Public Health. 13(1). 1210–1210. 47 indexed citations
17.
Zhang, Dengyou, Jing Ai, Zhongjie Liang, et al.. (2012). Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry. 20(17). 5169–5180. 27 indexed citations
18.
Wang, Yong, Zhongliang Xu, Jing Ai, et al.. (2012). Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors. Organic & Biomolecular Chemistry. 11(9). 1545–1562. 16 indexed citations
19.
Wu, Kui, Jing Ai, Qiufeng Liu, et al.. (2012). Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(20). 6368–6372. 33 indexed citations
20.
He, Xiu‐Feng, Sheng Yin, Yinchun Ji, et al.. (2009). Sesquiterpenes and Dimeric Sesquiterpenoids from Sarcandra glabra. Journal of Natural Products. 73(1). 45–50. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wufu Zhu Breakdown of academic impact, for papers by Sung Yun Cho Breakdown of academic impact, for papers by Peter D. Gorycki Breakdown of academic impact, for papers by Yunting Luo Breakdown of academic impact, for papers by Joachim Blanz Breakdown of academic impact, for papers by Gregory R. Ott Breakdown of academic impact, for papers by Emile G. Plise Breakdown of academic impact, for papers by Yali Deng Breakdown of academic impact, for papers by Asaad Nematalla
Rankless by CCL
2026